Medical Care
Prenatal and Newborn Genetic Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 550068
- Pages: 131
- Figures: 217
- Views: 4
The global market for Prenatal and Newborn Genetic Testing was estimated to be worth US$ 2154.1 million in 2023 and is forecast to a readjusted size of US$ 2917.1 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030
North American market for Prenatal and Newborn Genetic Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prenatal and Newborn Genetic Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Prenatal and Newborn Genetic Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Prenatal and Newborn Genetic Testing include Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics and Quest Diagnostic, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prenatal and Newborn Genetic Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Prenatal and Newborn Genetic Testing by region & country, by Type, and by Application.
The Prenatal and Newborn Genetic Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal and Newborn Genetic Testing.
Market Segmentation
By Company
Roche Diagnostic
Elitech Group
Myriad Genetics
Biocartis
IntegraGen
Perkin Elmer
WaferGen Biosystem
Interpace Diagnostics
Quest Diagnostic
Bio-Rad
AutoGenomics
Abbott
Cepheid
EKF Diagnostics
Natera
Agilent Technologies
Illumina
Ariosa Diagnostics
Sequenom
Segment by Type:
Array-Comparative Genetic Hybridization(aCGH)
Fluorescence In-Situ Hybridization(FISH)
Polymerase Chain Reaction(PCR)
Segment by Application
Hospitals
Diagnostic Organization
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Prenatal and Newborn Genetic Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Prenatal and Newborn Genetic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Prenatal and Newborn Genetic Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Prenatal and Newborn Genetic Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prenatal and Newborn Genetic Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Prenatal and Newborn Genetic Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Prenatal and Newborn Genetic Testing include Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics and Quest Diagnostic, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prenatal and Newborn Genetic Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Prenatal and Newborn Genetic Testing by region & country, by Type, and by Application.
The Prenatal and Newborn Genetic Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal and Newborn Genetic Testing.
Market Segmentation
By Company
Roche Diagnostic
Elitech Group
Myriad Genetics
Biocartis
IntegraGen
Perkin Elmer
WaferGen Biosystem
Interpace Diagnostics
Quest Diagnostic
Bio-Rad
AutoGenomics
Abbott
Cepheid
EKF Diagnostics
Natera
Agilent Technologies
Illumina
Ariosa Diagnostics
Sequenom
Segment by Type:
Array-Comparative Genetic Hybridization(aCGH)
Fluorescence In-Situ Hybridization(FISH)
Polymerase Chain Reaction(PCR)
Segment by Application
Hospitals
Diagnostic Organization
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Prenatal and Newborn Genetic Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Prenatal and Newborn Genetic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Prenatal and Newborn Genetic Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Prenatal and Newborn Genetic Testing Product Introduction
1.2 Global Prenatal and Newborn Genetic Testing Market Size Forecast
1.3 Prenatal and Newborn Genetic Testing Market Trends & Drivers
1.3.1 Prenatal and Newborn Genetic Testing Industry Trends
1.3.2 Prenatal and Newborn Genetic Testing Market Drivers & Opportunity
1.3.3 Prenatal and Newborn Genetic Testing Market Challenges
1.3.4 Prenatal and Newborn Genetic Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prenatal and Newborn Genetic Testing Players Revenue Ranking (2023)
2.2 Global Prenatal and Newborn Genetic Testing Revenue by Company (2019-2024)
2.3 Key Companies Prenatal and Newborn Genetic Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Prenatal and Newborn Genetic Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Prenatal and Newborn Genetic Testing
2.6 Prenatal and Newborn Genetic Testing Market Competitive Analysis
2.6.1 Prenatal and Newborn Genetic Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Prenatal and Newborn Genetic Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal and Newborn Genetic Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Array-Comparative Genetic Hybridization(aCGH)
3.1.2 Fluorescence In-Situ Hybridization(FISH)
3.1.3 Polymerase Chain Reaction(PCR)
3.2 Global Prenatal and Newborn Genetic Testing Sales Value by Type
3.2.1 Global Prenatal and Newborn Genetic Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Prenatal and Newborn Genetic Testing Sales Value, by Type (2019-2030)
3.2.3 Global Prenatal and Newborn Genetic Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Diagnostic Organization
4.1.3 Other
4.2 Global Prenatal and Newborn Genetic Testing Sales Value by Application
4.2.1 Global Prenatal and Newborn Genetic Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Prenatal and Newborn Genetic Testing Sales Value, by Application (2019-2030)
4.2.3 Global Prenatal and Newborn Genetic Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Prenatal and Newborn Genetic Testing Sales Value by Region
5.1.1 Global Prenatal and Newborn Genetic Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Prenatal and Newborn Genetic Testing Sales Value by Region (2019-2024)
5.1.3 Global Prenatal and Newborn Genetic Testing Sales Value by Region (2025-2030)
5.1.4 Global Prenatal and Newborn Genetic Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.2.2 North America Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.3.2 Europe Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.5.2 South America Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value
6.3 United States
6.3.1 United States Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.3.2 United States Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.4.2 Europe Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.5.2 China Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.6.2 Japan Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.7.2 South Korea Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.9.2 India Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche Diagnostic
7.1.1 Roche Diagnostic Profile
7.1.2 Roche Diagnostic Main Business
7.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.1.4 Roche Diagnostic Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Diagnostic Recent Developments
7.2 Elitech Group
7.2.1 Elitech Group Profile
7.2.2 Elitech Group Main Business
7.2.3 Elitech Group Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.2.4 Elitech Group Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Elitech Group Recent Developments
7.3 Myriad Genetics
7.3.1 Myriad Genetics Profile
7.3.2 Myriad Genetics Main Business
7.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.3.4 Myriad Genetics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Biocartis Recent Developments
7.4 Biocartis
7.4.1 Biocartis Profile
7.4.2 Biocartis Main Business
7.4.3 Biocartis Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.4.4 Biocartis Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Biocartis Recent Developments
7.5 IntegraGen
7.5.1 IntegraGen Profile
7.5.2 IntegraGen Main Business
7.5.3 IntegraGen Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.5.4 IntegraGen Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.5.5 IntegraGen Recent Developments
7.6 Perkin Elmer
7.6.1 Perkin Elmer Profile
7.6.2 Perkin Elmer Main Business
7.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.6.4 Perkin Elmer Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Perkin Elmer Recent Developments
7.7 WaferGen Biosystem
7.7.1 WaferGen Biosystem Profile
7.7.2 WaferGen Biosystem Main Business
7.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.7.4 WaferGen Biosystem Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.7.5 WaferGen Biosystem Recent Developments
7.8 Interpace Diagnostics
7.8.1 Interpace Diagnostics Profile
7.8.2 Interpace Diagnostics Main Business
7.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.8.4 Interpace Diagnostics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Interpace Diagnostics Recent Developments
7.9 Quest Diagnostic
7.9.1 Quest Diagnostic Profile
7.9.2 Quest Diagnostic Main Business
7.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.9.4 Quest Diagnostic Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Quest Diagnostic Recent Developments
7.10 Bio-Rad
7.10.1 Bio-Rad Profile
7.10.2 Bio-Rad Main Business
7.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.10.4 Bio-Rad Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Bio-Rad Recent Developments
7.11 AutoGenomics
7.11.1 AutoGenomics Profile
7.11.2 AutoGenomics Main Business
7.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.11.4 AutoGenomics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.11.5 AutoGenomics Recent Developments
7.12 Abbott
7.12.1 Abbott Profile
7.12.2 Abbott Main Business
7.12.3 Abbott Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.12.4 Abbott Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Abbott Recent Developments
7.13 Cepheid
7.13.1 Cepheid Profile
7.13.2 Cepheid Main Business
7.13.3 Cepheid Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.13.4 Cepheid Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Cepheid Recent Developments
7.14 EKF Diagnostics
7.14.1 EKF Diagnostics Profile
7.14.2 EKF Diagnostics Main Business
7.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.14.4 EKF Diagnostics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.14.5 EKF Diagnostics Recent Developments
7.15 Natera
7.15.1 Natera Profile
7.15.2 Natera Main Business
7.15.3 Natera Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.15.4 Natera Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.15.5 Natera Recent Developments
7.16 Agilent Technologies
7.16.1 Agilent Technologies Profile
7.16.2 Agilent Technologies Main Business
7.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.16.4 Agilent Technologies Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.16.5 Agilent Technologies Recent Developments
7.17 Illumina
7.17.1 Illumina Profile
7.17.2 Illumina Main Business
7.17.3 Illumina Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.17.4 Illumina Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.17.5 Illumina Recent Developments
7.18 Ariosa Diagnostics
7.18.1 Ariosa Diagnostics Profile
7.18.2 Ariosa Diagnostics Main Business
7.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.18.4 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.18.5 Ariosa Diagnostics Recent Developments
7.19 Sequenom
7.19.1 Sequenom Profile
7.19.2 Sequenom Main Business
7.19.3 Sequenom Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.19.4 Sequenom Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.19.5 Sequenom Recent Developments
8 Industry Chain Analysis
8.1 Prenatal and Newborn Genetic Testing Industrial Chain
8.2 Prenatal and Newborn Genetic Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Prenatal and Newborn Genetic Testing Sales Model
8.5.2 Sales Channel
8.5.3 Prenatal and Newborn Genetic Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Prenatal and Newborn Genetic Testing Product Introduction
1.2 Global Prenatal and Newborn Genetic Testing Market Size Forecast
1.3 Prenatal and Newborn Genetic Testing Market Trends & Drivers
1.3.1 Prenatal and Newborn Genetic Testing Industry Trends
1.3.2 Prenatal and Newborn Genetic Testing Market Drivers & Opportunity
1.3.3 Prenatal and Newborn Genetic Testing Market Challenges
1.3.4 Prenatal and Newborn Genetic Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prenatal and Newborn Genetic Testing Players Revenue Ranking (2023)
2.2 Global Prenatal and Newborn Genetic Testing Revenue by Company (2019-2024)
2.3 Key Companies Prenatal and Newborn Genetic Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Prenatal and Newborn Genetic Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Prenatal and Newborn Genetic Testing
2.6 Prenatal and Newborn Genetic Testing Market Competitive Analysis
2.6.1 Prenatal and Newborn Genetic Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Prenatal and Newborn Genetic Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal and Newborn Genetic Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Array-Comparative Genetic Hybridization(aCGH)
3.1.2 Fluorescence In-Situ Hybridization(FISH)
3.1.3 Polymerase Chain Reaction(PCR)
3.2 Global Prenatal and Newborn Genetic Testing Sales Value by Type
3.2.1 Global Prenatal and Newborn Genetic Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Prenatal and Newborn Genetic Testing Sales Value, by Type (2019-2030)
3.2.3 Global Prenatal and Newborn Genetic Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Diagnostic Organization
4.1.3 Other
4.2 Global Prenatal and Newborn Genetic Testing Sales Value by Application
4.2.1 Global Prenatal and Newborn Genetic Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Prenatal and Newborn Genetic Testing Sales Value, by Application (2019-2030)
4.2.3 Global Prenatal and Newborn Genetic Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Prenatal and Newborn Genetic Testing Sales Value by Region
5.1.1 Global Prenatal and Newborn Genetic Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Prenatal and Newborn Genetic Testing Sales Value by Region (2019-2024)
5.1.3 Global Prenatal and Newborn Genetic Testing Sales Value by Region (2025-2030)
5.1.4 Global Prenatal and Newborn Genetic Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.2.2 North America Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.3.2 Europe Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.5.2 South America Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value
6.3 United States
6.3.1 United States Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.3.2 United States Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.4.2 Europe Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.5.2 China Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.6.2 Japan Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.7.2 South Korea Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Prenatal and Newborn Genetic Testing Sales Value, 2019-2030
6.9.2 India Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Prenatal and Newborn Genetic Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche Diagnostic
7.1.1 Roche Diagnostic Profile
7.1.2 Roche Diagnostic Main Business
7.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.1.4 Roche Diagnostic Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Diagnostic Recent Developments
7.2 Elitech Group
7.2.1 Elitech Group Profile
7.2.2 Elitech Group Main Business
7.2.3 Elitech Group Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.2.4 Elitech Group Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Elitech Group Recent Developments
7.3 Myriad Genetics
7.3.1 Myriad Genetics Profile
7.3.2 Myriad Genetics Main Business
7.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.3.4 Myriad Genetics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Biocartis Recent Developments
7.4 Biocartis
7.4.1 Biocartis Profile
7.4.2 Biocartis Main Business
7.4.3 Biocartis Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.4.4 Biocartis Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Biocartis Recent Developments
7.5 IntegraGen
7.5.1 IntegraGen Profile
7.5.2 IntegraGen Main Business
7.5.3 IntegraGen Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.5.4 IntegraGen Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.5.5 IntegraGen Recent Developments
7.6 Perkin Elmer
7.6.1 Perkin Elmer Profile
7.6.2 Perkin Elmer Main Business
7.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.6.4 Perkin Elmer Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Perkin Elmer Recent Developments
7.7 WaferGen Biosystem
7.7.1 WaferGen Biosystem Profile
7.7.2 WaferGen Biosystem Main Business
7.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.7.4 WaferGen Biosystem Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.7.5 WaferGen Biosystem Recent Developments
7.8 Interpace Diagnostics
7.8.1 Interpace Diagnostics Profile
7.8.2 Interpace Diagnostics Main Business
7.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.8.4 Interpace Diagnostics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Interpace Diagnostics Recent Developments
7.9 Quest Diagnostic
7.9.1 Quest Diagnostic Profile
7.9.2 Quest Diagnostic Main Business
7.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.9.4 Quest Diagnostic Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Quest Diagnostic Recent Developments
7.10 Bio-Rad
7.10.1 Bio-Rad Profile
7.10.2 Bio-Rad Main Business
7.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.10.4 Bio-Rad Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Bio-Rad Recent Developments
7.11 AutoGenomics
7.11.1 AutoGenomics Profile
7.11.2 AutoGenomics Main Business
7.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.11.4 AutoGenomics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.11.5 AutoGenomics Recent Developments
7.12 Abbott
7.12.1 Abbott Profile
7.12.2 Abbott Main Business
7.12.3 Abbott Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.12.4 Abbott Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.12.5 Abbott Recent Developments
7.13 Cepheid
7.13.1 Cepheid Profile
7.13.2 Cepheid Main Business
7.13.3 Cepheid Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.13.4 Cepheid Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.13.5 Cepheid Recent Developments
7.14 EKF Diagnostics
7.14.1 EKF Diagnostics Profile
7.14.2 EKF Diagnostics Main Business
7.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.14.4 EKF Diagnostics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.14.5 EKF Diagnostics Recent Developments
7.15 Natera
7.15.1 Natera Profile
7.15.2 Natera Main Business
7.15.3 Natera Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.15.4 Natera Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.15.5 Natera Recent Developments
7.16 Agilent Technologies
7.16.1 Agilent Technologies Profile
7.16.2 Agilent Technologies Main Business
7.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.16.4 Agilent Technologies Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.16.5 Agilent Technologies Recent Developments
7.17 Illumina
7.17.1 Illumina Profile
7.17.2 Illumina Main Business
7.17.3 Illumina Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.17.4 Illumina Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.17.5 Illumina Recent Developments
7.18 Ariosa Diagnostics
7.18.1 Ariosa Diagnostics Profile
7.18.2 Ariosa Diagnostics Main Business
7.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.18.4 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.18.5 Ariosa Diagnostics Recent Developments
7.19 Sequenom
7.19.1 Sequenom Profile
7.19.2 Sequenom Main Business
7.19.3 Sequenom Prenatal and Newborn Genetic Testing Products, Services and Solutions
7.19.4 Sequenom Prenatal and Newborn Genetic Testing Revenue (US$ Million) & (2019-2024)
7.19.5 Sequenom Recent Developments
8 Industry Chain Analysis
8.1 Prenatal and Newborn Genetic Testing Industrial Chain
8.2 Prenatal and Newborn Genetic Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Prenatal and Newborn Genetic Testing Sales Model
8.5.2 Sales Channel
8.5.3 Prenatal and Newborn Genetic Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Prenatal and Newborn Genetic Testing Market Trends
Table 2. Prenatal and Newborn Genetic Testing Market Drivers & Opportunity
Table 3. Prenatal and Newborn Genetic Testing Market Challenges
Table 4. Prenatal and Newborn Genetic Testing Market Restraints
Table 5. Global Prenatal and Newborn Genetic Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Prenatal and Newborn Genetic Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Prenatal and Newborn Genetic Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Prenatal and Newborn Genetic Testing
Table 10. Global Prenatal and Newborn Genetic Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal and Newborn Genetic Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Prenatal and Newborn Genetic Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Prenatal and Newborn Genetic Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Prenatal and Newborn Genetic Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Prenatal and Newborn Genetic Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Prenatal and Newborn Genetic Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Prenatal and Newborn Genetic Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Prenatal and Newborn Genetic Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Prenatal and Newborn Genetic Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Prenatal and Newborn Genetic Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Prenatal and Newborn Genetic Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Prenatal and Newborn Genetic Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Prenatal and Newborn Genetic Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Prenatal and Newborn Genetic Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Prenatal and Newborn Genetic Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Prenatal and Newborn Genetic Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Diagnostic Basic Information List
Table 32. Roche Diagnostic Description and Business Overview
Table 33. Roche Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Roche Diagnostic (2019-2024)
Table 35. Roche Diagnostic Recent Developments
Table 36. Elitech Group Basic Information List
Table 37. Elitech Group Description and Business Overview
Table 38. Elitech Group Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Elitech Group (2019-2024)
Table 40. Elitech Group Recent Developments
Table 41. Myriad Genetics Basic Information List
Table 42. Myriad Genetics Description and Business Overview
Table 43. Myriad Genetics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Myriad Genetics (2019-2024)
Table 45. Myriad Genetics Recent Developments
Table 46. Biocartis Basic Information List
Table 47. Biocartis Description and Business Overview
Table 48. Biocartis Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Biocartis (2019-2024)
Table 50. Biocartis Recent Developments
Table 51. IntegraGen Basic Information List
Table 52. IntegraGen Description and Business Overview
Table 53. IntegraGen Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of IntegraGen (2019-2024)
Table 55. IntegraGen Recent Developments
Table 56. Perkin Elmer Basic Information List
Table 57. Perkin Elmer Description and Business Overview
Table 58. Perkin Elmer Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Perkin Elmer (2019-2024)
Table 60. Perkin Elmer Recent Developments
Table 61. WaferGen Biosystem Basic Information List
Table 62. WaferGen Biosystem Description and Business Overview
Table 63. WaferGen Biosystem Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of WaferGen Biosystem (2019-2024)
Table 65. WaferGen Biosystem Recent Developments
Table 66. Interpace Diagnostics Basic Information List
Table 67. Interpace Diagnostics Description and Business Overview
Table 68. Interpace Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Interpace Diagnostics (2019-2024)
Table 70. Interpace Diagnostics Recent Developments
Table 71. Quest Diagnostic Basic Information List
Table 72. Quest Diagnostic Description and Business Overview
Table 73. Quest Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Quest Diagnostic (2019-2024)
Table 75. Quest Diagnostic Recent Developments
Table 76. Bio-Rad Basic Information List
Table 77. Bio-Rad Description and Business Overview
Table 78. Bio-Rad Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Bio-Rad (2019-2024)
Table 80. Bio-Rad Recent Developments
Table 81. AutoGenomics Basic Information List
Table 82. AutoGenomics Description and Business Overview
Table 83. AutoGenomics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 84. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of AutoGenomics (2019-2024)
Table 85. AutoGenomics Recent Developments
Table 86. Abbott Basic Information List
Table 87. Abbott Description and Business Overview
Table 88. Abbott Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 89. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Abbott (2019-2024)
Table 90. Abbott Recent Developments
Table 91. Cepheid Basic Information List
Table 92. Cepheid Description and Business Overview
Table 93. Cepheid Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 94. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Cepheid (2019-2024)
Table 95. Cepheid Recent Developments
Table 96. EKF Diagnostics Basic Information List
Table 97. EKF Diagnostics Description and Business Overview
Table 98. EKF Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 99. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of EKF Diagnostics (2019-2024)
Table 100. EKF Diagnostics Recent Developments
Table 101. Natera Basic Information List
Table 102. Natera Description and Business Overview
Table 103. Natera Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 104. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Natera (2019-2024)
Table 105. Natera Recent Developments
Table 106. Agilent Technologies Basic Information List
Table 107. Agilent Technologies Description and Business Overview
Table 108. Agilent Technologies Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 109. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Agilent Technologies (2019-2024)
Table 110. Agilent Technologies Recent Developments
Table 111. Illumina Basic Information List
Table 112. Illumina Description and Business Overview
Table 113. Illumina Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 114. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Illumina (2019-2024)
Table 115. Illumina Recent Developments
Table 116. Ariosa Diagnostics Basic Information List
Table 117. Ariosa Diagnostics Description and Business Overview
Table 118. Ariosa Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 119. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Ariosa Diagnostics (2019-2024)
Table 120. Ariosa Diagnostics Recent Developments
Table 121. Sequenom Basic Information List
Table 122. Sequenom Description and Business Overview
Table 123. Sequenom Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 124. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Sequenom (2019-2024)
Table 125. Sequenom Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Prenatal and Newborn Genetic Testing Downstream Customers
Table 129. Prenatal and Newborn Genetic Testing Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Prenatal and Newborn Genetic Testing Product Picture
Figure 2. Global Prenatal and Newborn Genetic Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Prenatal and Newborn Genetic Testing Report Years Considered
Figure 5. Global Prenatal and Newborn Genetic Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Prenatal and Newborn Genetic Testing Revenue in 2023
Figure 7. Prenatal and Newborn Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Array-Comparative Genetic Hybridization(aCGH) Picture
Figure 9. Fluorescence In-Situ Hybridization(FISH) Picture
Figure 10. Polymerase Chain Reaction(PCR) Picture
Figure 11. Global Prenatal and Newborn Genetic Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Prenatal and Newborn Genetic Testing Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Diagnostic Organization
Figure 15. Product Picture of Other
Figure 16. Global Prenatal and Newborn Genetic Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Prenatal and Newborn Genetic Testing Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value (%), (2019-2030)
Figure 29. United States Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 35. China Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 37. China Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 47. India Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 49. India Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 50. Prenatal and Newborn Genetic Testing Industrial Chain
Figure 51. Prenatal and Newborn Genetic Testing Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Table 1. Prenatal and Newborn Genetic Testing Market Trends
Table 2. Prenatal and Newborn Genetic Testing Market Drivers & Opportunity
Table 3. Prenatal and Newborn Genetic Testing Market Challenges
Table 4. Prenatal and Newborn Genetic Testing Market Restraints
Table 5. Global Prenatal and Newborn Genetic Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Prenatal and Newborn Genetic Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Prenatal and Newborn Genetic Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Prenatal and Newborn Genetic Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Prenatal and Newborn Genetic Testing
Table 10. Global Prenatal and Newborn Genetic Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal and Newborn Genetic Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Prenatal and Newborn Genetic Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Prenatal and Newborn Genetic Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Prenatal and Newborn Genetic Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Prenatal and Newborn Genetic Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Prenatal and Newborn Genetic Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Prenatal and Newborn Genetic Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Prenatal and Newborn Genetic Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Prenatal and Newborn Genetic Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Prenatal and Newborn Genetic Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Prenatal and Newborn Genetic Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Prenatal and Newborn Genetic Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Prenatal and Newborn Genetic Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Prenatal and Newborn Genetic Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Prenatal and Newborn Genetic Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Prenatal and Newborn Genetic Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Diagnostic Basic Information List
Table 32. Roche Diagnostic Description and Business Overview
Table 33. Roche Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Roche Diagnostic (2019-2024)
Table 35. Roche Diagnostic Recent Developments
Table 36. Elitech Group Basic Information List
Table 37. Elitech Group Description and Business Overview
Table 38. Elitech Group Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Elitech Group (2019-2024)
Table 40. Elitech Group Recent Developments
Table 41. Myriad Genetics Basic Information List
Table 42. Myriad Genetics Description and Business Overview
Table 43. Myriad Genetics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Myriad Genetics (2019-2024)
Table 45. Myriad Genetics Recent Developments
Table 46. Biocartis Basic Information List
Table 47. Biocartis Description and Business Overview
Table 48. Biocartis Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Biocartis (2019-2024)
Table 50. Biocartis Recent Developments
Table 51. IntegraGen Basic Information List
Table 52. IntegraGen Description and Business Overview
Table 53. IntegraGen Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of IntegraGen (2019-2024)
Table 55. IntegraGen Recent Developments
Table 56. Perkin Elmer Basic Information List
Table 57. Perkin Elmer Description and Business Overview
Table 58. Perkin Elmer Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Perkin Elmer (2019-2024)
Table 60. Perkin Elmer Recent Developments
Table 61. WaferGen Biosystem Basic Information List
Table 62. WaferGen Biosystem Description and Business Overview
Table 63. WaferGen Biosystem Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of WaferGen Biosystem (2019-2024)
Table 65. WaferGen Biosystem Recent Developments
Table 66. Interpace Diagnostics Basic Information List
Table 67. Interpace Diagnostics Description and Business Overview
Table 68. Interpace Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Interpace Diagnostics (2019-2024)
Table 70. Interpace Diagnostics Recent Developments
Table 71. Quest Diagnostic Basic Information List
Table 72. Quest Diagnostic Description and Business Overview
Table 73. Quest Diagnostic Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Quest Diagnostic (2019-2024)
Table 75. Quest Diagnostic Recent Developments
Table 76. Bio-Rad Basic Information List
Table 77. Bio-Rad Description and Business Overview
Table 78. Bio-Rad Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Bio-Rad (2019-2024)
Table 80. Bio-Rad Recent Developments
Table 81. AutoGenomics Basic Information List
Table 82. AutoGenomics Description and Business Overview
Table 83. AutoGenomics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 84. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of AutoGenomics (2019-2024)
Table 85. AutoGenomics Recent Developments
Table 86. Abbott Basic Information List
Table 87. Abbott Description and Business Overview
Table 88. Abbott Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 89. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Abbott (2019-2024)
Table 90. Abbott Recent Developments
Table 91. Cepheid Basic Information List
Table 92. Cepheid Description and Business Overview
Table 93. Cepheid Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 94. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Cepheid (2019-2024)
Table 95. Cepheid Recent Developments
Table 96. EKF Diagnostics Basic Information List
Table 97. EKF Diagnostics Description and Business Overview
Table 98. EKF Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 99. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of EKF Diagnostics (2019-2024)
Table 100. EKF Diagnostics Recent Developments
Table 101. Natera Basic Information List
Table 102. Natera Description and Business Overview
Table 103. Natera Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 104. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Natera (2019-2024)
Table 105. Natera Recent Developments
Table 106. Agilent Technologies Basic Information List
Table 107. Agilent Technologies Description and Business Overview
Table 108. Agilent Technologies Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 109. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Agilent Technologies (2019-2024)
Table 110. Agilent Technologies Recent Developments
Table 111. Illumina Basic Information List
Table 112. Illumina Description and Business Overview
Table 113. Illumina Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 114. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Illumina (2019-2024)
Table 115. Illumina Recent Developments
Table 116. Ariosa Diagnostics Basic Information List
Table 117. Ariosa Diagnostics Description and Business Overview
Table 118. Ariosa Diagnostics Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 119. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Ariosa Diagnostics (2019-2024)
Table 120. Ariosa Diagnostics Recent Developments
Table 121. Sequenom Basic Information List
Table 122. Sequenom Description and Business Overview
Table 123. Sequenom Prenatal and Newborn Genetic Testing Products, Services and Solutions
Table 124. Revenue (US$ Million) in Prenatal and Newborn Genetic Testing Business of Sequenom (2019-2024)
Table 125. Sequenom Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Prenatal and Newborn Genetic Testing Downstream Customers
Table 129. Prenatal and Newborn Genetic Testing Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Prenatal and Newborn Genetic Testing Product Picture
Figure 2. Global Prenatal and Newborn Genetic Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Prenatal and Newborn Genetic Testing Report Years Considered
Figure 5. Global Prenatal and Newborn Genetic Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Prenatal and Newborn Genetic Testing Revenue in 2023
Figure 7. Prenatal and Newborn Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Array-Comparative Genetic Hybridization(aCGH) Picture
Figure 9. Fluorescence In-Situ Hybridization(FISH) Picture
Figure 10. Polymerase Chain Reaction(PCR) Picture
Figure 11. Global Prenatal and Newborn Genetic Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Prenatal and Newborn Genetic Testing Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Hospitals
Figure 14. Product Picture of Diagnostic Organization
Figure 15. Product Picture of Other
Figure 16. Global Prenatal and Newborn Genetic Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Prenatal and Newborn Genetic Testing Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Prenatal and Newborn Genetic Testing Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Prenatal and Newborn Genetic Testing Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Prenatal and Newborn Genetic Testing Sales Value (%), (2019-2030)
Figure 29. United States Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 35. China Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 37. China Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 47. India Prenatal and Newborn Genetic Testing Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Prenatal and Newborn Genetic Testing Sales Value by Type (%), 2023 VS 2030
Figure 49. India Prenatal and Newborn Genetic Testing Sales Value by Application (%), 2023 VS 2030
Figure 50. Prenatal and Newborn Genetic Testing Industrial Chain
Figure 51. Prenatal and Newborn Genetic Testing Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232